-
TAGMe DNA Methylation Detection Kits(qPCR) for Cervical Cancer
This product is used for in vitro qualitative detection of hypermethylation of the gene PCDHGB7 in cervical specimens.
Test method: Fluorescence quantitative PCR technology
Sample type: Female cervical specimens
Packing specification: 48 tests/kit
-
TAGMe DNA Methylation Detection Kits (qPCR) for Endometrial Cancer
This product is used for in vitro qualitative detection of hypermethylation of the gene PCDHGB7 in cervical specimens.
Test method: Fluorescence quantitative PCR technology
Sample type: Female cervical specimens
Packing specification: 48 tests/kit
-
TAGMe DNA Methylation Detection Kits (qPCR) for Urothelial Cancer
This product is used for in vitro qualitative detection of hypermethylation of the Urothelial Carcinoma(UC) gene in urothelial specimens.
Test method: Fluorescence quantitative PCR technology
Sample type: Urine exfoliated cell sample (urine sediment)
Packing specification: 48 tests/kit
-
TAGMe DNA Methylation Detection Kits (qPCR) for Urothelial Cancer
This product is used for in vitro qualitative detection of hypermethylation of the Urothelial Carcinoma(UC) gene in urothelial specimens.
Test method: Fluorescence quantitative PCR technology
Sample type: Urine exfoliated cell sample (urine sediment)
Packing specification: 48 tests/kit
-
TAGMe DNA Methylation Detection Kits (qPCR) for Cervical Cancer / Endometrial Cancer
This product is used for in vitro qualitative detection of hypermethylation of the gene PCDHGB7 in cervical specimens.
Test method: Fluorescence quantitative PCR technology
Sample type: Female cervical specimens
Packing specification: 48 tests/kit
-
TAGMe DNA Methylation Detection for Pan-cancer
The whole-cancer detection is the plasma ctDNA methylation test products that are developed by TAGMe, which requires at least 3ml of whole blood to effectively capture and determine the methylation status of ctDNA’s special positioning points, so as to achieve the early screening and accurate monitoring of the tumor.
